Telescope Grants Stock Options, RSUs and Settles Debt with Shares

Core Viewpoint - Telescope Innovations Corp. has authorized the grant of stock options, restricted share units, and the issuance of common shares to settle outstanding fees owed to its CEO [1] Stock Option Grant - The company has granted stock options to a consultant, allowing the acquisition of up to 250,000 common shares at a price of $0.33 per share until December 31, 2030, with vesting occurring quarterly over four months and then annually for three years [2] RSU Grant - A total of 192,000 restricted share units have been granted to three directors as part of their compensation arrangements for 2024 and 2025, valued at $48,000, with similar vesting terms as the stock options [3] Shares for Debt - CEO Henry Dubina will settle $12,000 of outstanding debt through the issuance of 48,000 common shares at a deemed price of $0.25 per share, subject to a four-month hold period [4] Related Party Transaction - The share issuance to Mr. Dubina is classified as a related party transaction, and the company will rely on exemptions from formal valuation and minority approval requirements as the transaction does not exceed 25% of the company's market capitalization [5] Company Overview - Telescope Innovations is focused on developing scalable manufacturing processes and tools for the pharmaceutical and chemical industries, utilizing advanced technologies such as flexible robotic platforms and AI software to enhance efficiency and data quality [6]